These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 15887642)

  • 21. The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review.
    Chohan G; Pennington C; Mackenzie JM; Andrews M; Everington D; Will RG; Knight RS; Green AJ
    J Neurol Neurosurg Psychiatry; 2010 Nov; 81(11):1243-8. PubMed ID: 20855493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated levels of tau protein in cerebrospinal fluid of patients with probable Creutzfeldt-Jakob disease.
    Wang GR; Gao C; Shi Q; Zhou W; Chen JM; Dong CF; Shi S; Wang X; Wei Y; Jiang HY; Han J; Dong XP
    Am J Med Sci; 2010 Oct; 340(4):291-5. PubMed ID: 20881758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sporadic Creutzfeldt-Jakob disease diagnostic accuracy is improved by a new CSF ELISA 14-3-3γ assay.
    Leitão MJ; Baldeiras I; Almeida MR; Ribeiro MH; Santos AC; Ribeiro M; Tomás J; Rocha S; Santana I; Oliveira CR
    Neuroscience; 2016 May; 322():398-407. PubMed ID: 26940479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison Between Sporadic and Misdiagnosed Sporadic Creutzfeldt-Jakob Disease: A Report of Two Cases.
    Zhao X; Yu Y; Zhao Z; Xu J
    Cell Biochem Biophys; 2015 Jun; 72(2):311-5. PubMed ID: 25556070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein.
    Grangeon L; Paquet C; Bombois S; Quillard-Muraine M; Martinaud O; Bourre B; Lefaucheur R; Nicolas G; Dumurgier J; Gerardin E; Jan M; Laplanche JL; Peoc'h K; Hugon J; Pasquier F; Maltête D; Hannequin D; Wallon D;
    J Alzheimers Dis; 2016; 51(3):905-13. PubMed ID: 26890785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronological changes in MRI and CSF biochemical markers in Creutzfeldt-Jakob disease patients.
    Satoh K; Shirabe S; Eguchi H; Tsujino A; Motomura M; Satoh A; Tsujihata M; Eguchi K
    Dement Geriatr Cogn Disord; 2007; 23(6):372-81. PubMed ID: 17389797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias.
    Riemenschneider M; Wagenpfeil S; Vanderstichele H; Otto M; Wiltfang J; Kretzschmar H; Vanmechelen E; Förstl H; Kurz A
    Mol Psychiatry; 2003 Mar; 8(3):343-7. PubMed ID: 12660807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic value of surrogate CSF biomarkers for Creutzfeldt-Jakob disease in the era of RT-QuIC.
    Abu-Rumeileh S; Baiardi S; Polischi B; Mammana A; Franceschini A; Green A; Capellari S; Parchi P
    J Neurol; 2019 Dec; 266(12):3136-3143. PubMed ID: 31541342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follow-up investigations of tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
    Cepek L; Steinacker P; Mollenhauer B; Wiese B; Ciesielczyk B; Bibl M; Wiltfang J; Zerr I; Schulz-Schaeffer W; Kretzschmar HA; Poser S; Otto M
    Dement Geriatr Cogn Disord; 2005; 19(5-6):376-82. PubMed ID: 15802913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 14-3-3 protein, total tau and phosphorylated tau in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease and neurodegenerative disease in Japan.
    Satoh K; Shirabe S; Eguchi H; Tsujino A; Eguchi K; Satoh A; Tsujihata M; Niwa M; Katamine S; Kurihara S; Matsuo H
    Cell Mol Neurobiol; 2006 Feb; 26(1):45-52. PubMed ID: 16633900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease.
    Van Everbroeck B; Quoilin S; Boons J; Martin JJ; Cras P
    J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1210-4. PubMed ID: 12933920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients.
    Baldeiras IE; Ribeiro MH; Pacheco P; Machado A; Santana I; Cunha L; Oliveira CR
    J Neurol; 2009 Sep; 256(9):1540-50. PubMed ID: 19418113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteinase-activated receptor 2 and disease biomarkers in cerebrospinal fluid in cases with autopsy-confirmed prion diseases and other neurodegenerative diseases.
    Rohan Z; Smetakova M; Kukal J; Rusina R; Matej R
    BMC Neurol; 2015 Mar; 15():50. PubMed ID: 25886404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease.
    Buerger K; Otto M; Teipel SJ; Zinkowski R; Blennow K; DeBernardis J; Kerkman D; Schröder J; Schönknecht P; Cepek L; McCulloch C; Möller HJ; Wiltfang J; Kretzschmar H; Hampel H
    Neurobiol Aging; 2006 Jan; 27(1):10-5. PubMed ID: 16298235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of Clinical Features, Diagnostic Tests, and Biomarkers in Patients With Suspected Creutzfeldt-Jakob Disease, 2014-2021.
    Shir D; Lazar EB; Graff-Radford J; Aksamit AJ; Cutsforth-Gregory JK; Jones DT; Botha H; Ramanan VK; Prusinski C; Porter A; Day GS
    JAMA Netw Open; 2022 Aug; 5(8):e2225098. PubMed ID: 35921110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years.
    Stoeck K; Sanchez-Juan P; Gawinecka J; Green A; Ladogana A; Pocchiari M; Sanchez-Valle R; Mitrova E; Sklaviadis T; Kulczycki J; Slivarichova D; Saiz A; Calero M; Knight R; Aguzzi A; Laplanche JL; Peoc'h K; Schelzke G; Karch A; van Duijn CM; Zerr I
    Brain; 2012 Oct; 135(Pt 10):3051-61. PubMed ID: 23012332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum tau protein as a marker for the diagnosis of Creutzfeldt-Jakob disease.
    Noguchi-Shinohara M; Hamaguchi T; Nozaki I; Sakai K; Yamada M
    J Neurol; 2011 Aug; 258(8):1464-8. PubMed ID: 21360196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prion disease: diagnostic value of cerebrospinal fluid markers.
    Parchi P; Capellari S
    Nat Rev Neurol; 2013 Jan; 9(1):10-1. PubMed ID: 23208112
    [No Abstract]   [Full Text] [Related]  

  • 39. Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study.
    Coulthart MB; Jansen GH; Olsen E; Godal DL; Connolly T; Choi BC; Wang Z; Cashman NR
    BMC Neurol; 2011 Oct; 11():133. PubMed ID: 22032272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of Korean patients with suspected Creutzfeldt-Jakob disease with 14-3-3 protein in cerebrospinal fluid: Preliminary study of the Korean Creutzfeldt-Jakob disease active surveillance program.
    Lim JS; Kwon HM; Jang JW; Ju YR; Kim S; Park YH; Park SY; Kim S
    Prion; 2015; 9(2):136-43. PubMed ID: 25996401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.